Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)

Hong Kong · Delayed Price · Currency is HKD

2.370

-0.005 (-0.21%)

Oct 30, 2026, 4:08 PM HKT

HKG:1349 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	664.43	685.8	709.4	850.73	1,031	1,140
Revenue Growth	-6.63%	-3.33%	-16.61%	-17.50%	-9.57%	36.76%
Gross Profit	603.56	614.96	645.95	776.66	944.87	1,059
Operating Income	-112.93	-159.87	-7.75	77.15	114.09	162.72
Net Income	-103.09	-157.44	39.73	108.63	138	213.3
Earnings Per Share	-0.09	-0.15	0.04	0.11	0.13	0.20
EPS Growth	-	-	-63.51%	-19.19%	-35.00%	20.17%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,274	1,147	1,056	1,196	1,319	1,209
Total Debt	10.65	14.69	20.53	17.28	124.81	31.26
Net Cash (Debt)	1,263	1,132	1,036	1,179	1,194	1,178
Net Cash Growth	14.57%	9.33%	-12.12%	-1.33%	1.43%	-14.49%
Net Cash Per Share	1.09	1.09	1.00	1.14	1.16	1.13

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	174.19	141.4	-16.51	71.02	165.27	268.9
Capital Expenditures	-26.27	-32.37	-42.67	-98.97	-87.3	-120.12
Free Cash Flow	147.92	109.03	-59.18	-27.95	77.96	148.78
Free Cash Flow Growth	48.97%	-	-	-	-47.60%	110.76%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	90.84%	89.67%	91.05%	91.29%	91.63%	92.90%
Operating Margin	-17.00%	-23.31%	-1.09%	9.07%	11.06%	14.27%
Pretax Margin	-15.28%	-22.73%	0.77%	11.46%	12.83%	18.94%
Profit Margin	-15.52%	-22.96%	5.60%	12.77%	13.38%	18.70%
FCF Margin	22.26%	15.90%	-8.34%	-3.29%	7.56%	13.05%

Dividends

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.050	0.070	0.070	0.070
Dividend Per Share Growth	-28.57%	0%	0%	40.00%
Dividend Yield	0.83%	0.99%	1.05%	0.66%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	156.13	67.32	49.79	51.31
Forward PE	-	22.46	22.46	22.46	22.46	22.46
P/FCF Ratio	38.06	61.56	-	-	88.13	73.56
PS Ratio	8.47	9.79	8.74	8.60	6.66	9.60